Oakbrook Investments’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-11,925
Closed -$956K 600
2016
Q4
$956K Sell
11,925
-3,550
-23% -$282K 0.06% 235
2016
Q3
$1.23M Sell
15,475
-2,100
-12% -$170K 0.08% 212
2016
Q2
$1.37M Sell
17,575
-9,650
-35% -$688K 0.08% 218
2016
Q1
$1.5M Buy
27,225
+1,950
+8% +$106K 0.1% 171
2015
Q4
$1.56M Buy
25,275
+7,350
+41% +$464K 0.1% 168
2015
Q3
$1.13M Sell
17,925
-250
-1% -$17.8K 0.07% 239
2015
Q2
$1.33M Sell
18,175
-24,150
-57% -$1.74M 0.08% 221
2015
Q1
$2.77M Sell
42,325
-700
-2% -$46.5K 0.15% 148
2014
Q4
$2.8M Sell
43,025
-2,450
-5% -$158K 0.15% 137
2014
Q3
$2.73M Sell
45,475
-44,150
-49% -$2.88M 0.15% 144
2014
Q2
$6.21M Sell
89,625
-1,950
-2% -$126K 0.19% 133
2014
Q1
$5.99M Sell
91,575
-18,500
-17% -$1.2M 0.19% 127
2013
Q4
$6.82M Sell
110,075
-3,575
-3% -$207K 0.19% 132
2013
Q3
$6.1M Buy
113,650
+52,200
+85% +$2.69M 0.18% 133
2013
Q2
$2.8M Buy
+61,450
New +$2.66M 0.08% 250

Other funds holding STJ

Oakbrook Investments's STJ Position: Q1 2017 in Review

Oakbrook Investments sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 11,925 shares — an estimated $956K sold.

Oakbrook Investments first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $6.82M in Q4 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Oakbrook Investments reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Oakbrook Investments sold 11,925 St Jude Medical shares in Q1 2017, an estimated $956K.
  • Oakbrook Investments first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Oakbrook Investments's St Jude Medical position peaked at $6.82M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Oakbrook Investments's 13F filing for Q1 2017, filed 20 Apr 2017.